Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...
STAAR Surgical has had an impressive run over the past six months as its shares have beaten the S&P 500 by 7.7%. The stock now trades at $27.81, marking a 16...
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they strugg...
Looking back on healthcare equipment and supplies stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Lantheus (NASDAQ:LNTH) ...
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...
While some companies burn cash to fuel expansion, others struggle to turn spending into sustainable growth. A high cash burn rate without a strong balance sh...
Let’s dig into the relative performance of STAAR Surgical (NASDAQ:STAA) and its peers as we unravel the now-completed Q1 medical devices & supplies - special...
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou...
STAAR Surgical’s first quarter performance was met with a strong positive market reaction, reflecting the company’s progress in resolving prior operational d...
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, pos...
Medical lens company STAAR Surgical (NASDAQ:STAA) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 120% year on year to $...
STAAR Surgical (NASDAQ:STAA) said its first quarter of 2026 marked a sharp rebound in sales and profitability, driven by strong demand in China, continued growth in the U.S. and tighter cost controls following a difficult 2025.
On the company’s earnings call, Interim Co-CEO, President and Chief Ope
Medical lens company STAAR Surgical (NASDAQ:STAA) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 120% year on year to ...
Medical lens company STAAR Surgical (NASDAQ:STAA) will be reporting results this Wednesday afternoon. Here’s what to expect. STAAR Surgical missed analysts’ ...
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recentl...
STAAR Surgical trades at $27.29 per share and has stayed right on track with the overall market, gaining 8.1% over the last six months. At the same time, the...
Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them...
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion o...
